Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (720)	7/19/1998 11:47:00 PM
From: Joe Senesac	Read Replies (1) \| Respond to of 834

Texas Biotech is not a Woodlands company. It is in Houston. Get your facts straight before you start cluttering up the thread again.

To: Bill Wexler who wrote (720)	7/21/1998 8:18:00 AM
From: Bharat H. Barai	Read Replies (1) \| Respond to of 834

Can you tell us what is the basis of your statement that Novastan is fraud? I realize that you are a stock broker and may have reasons to promote or bring down a particular company. Novastan-Argatroban is a drug already in use in Japan and is working well. I have personally spoken to several MDs who were using the drug during clinical trials and they all loved the drug. I have heard the experience of several leading Hematologists about Argatroban and they all spoke positively about the drug. The multi center trial in USA showed highly significant benefit. To most Hematologists, non approvable letter by FDA was a rude surprise. In past some low or middle level officials of FDA have shown such irrational behaviour. Later such drugs do get approved, based on the merits. I would be very surprised if Novastan does not get approved. B.H. Barai MD Hematologist